Valuation United Therapeutics Corporation

Stocks

Real-time Estimate Cboe BZX 12:59:08 2026-10-28 EDT			5-day change	1st Jan Change
584.95 ^USD	-1.06%		+3.90%	+20.16%

10:49am	United Therapeutics Wins FDA Clearance for Treprostinil-Iloprost Phase 1 Trial	MT
08:21am	United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	9,731	12,674	10,333	15,752	20,979	25,357	-	-
Change	-	30.24%	-18.47%	52.44%	33.18%	20.87%	-	-
Enterprise Value (EV) ¹	9,637	12,513	8,039	12,785	18,059	22,649	21,543	19,789
Change	-	29.85%	-35.75%	59.04%	41.25%	25.41%	-4.88%	-8.14%
P/E	21.5x	18.5x	11.1x	14.3x	17.5x	22.3x	18.9x	15.9x
PBR	2.67x	2.67x	1.73x	2.47x	3x	3.37x	2.85x	2.37x
PEG	-	0.4x	0.3x	0.6x	1.3x	-4.69x	1.1x	0.8x
Capitalization / Revenue	5.77x	6.55x	4.44x	5.47x	6.59x	7.96x	7x	6.16x
EV / Revenue	5.72x	6.46x	3.45x	4.44x	5.67x	7.11x	5.95x	4.8x
EV / EBITDA	15.9x	12.1x	6.49x	8.82x	11.4x	15.3x	12.3x	9.02x
EV / EBIT	17.3x	12.8x	6.78x	9.28x	12.1x	16.8x	13.2x	9.98x
EV / FCF	20.2x	18.9x	10.8x	11.8x	17.4x	18.3x	15.7x	10.9x
FCF Yield	4.95%	5.3%	9.3%	8.45%	5.76%	5.45%	6.35%	9.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.06	15	19.81	24.64	27.86	26.54	31.24	37.23
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,686	1,936	2,328	2,877	3,183	3,186	3,623	4,119
EBITDA ¹	605.8	1,031	1,238	1,450	1,578	1,483	1,755	2,195
EBIT ¹	555.9	979.7	1,185	1,377	1,492	1,350	1,636	1,983
Net income ¹	475.8	727.3	984.8	1,195	1,335	1,213	1,415	1,705
Net Debt ¹	-94.8	-161.2	-2,294	-2,967	-2,920	-2,708	-3,814	-5,568
Reference price ²	216.08	278.09	219.89	352.84	487.25	591.20	591.20	591.20
Nbr of stocks (in thousands)	45,037	45,577	46,994	44,645	43,057	42,891	-	-
Announcement Date	2/24/22	2/22/23	2/21/24	2/26/25	2/25/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNITED THERAPEUTICS CORPORATION	22.28x	7.11x	15.27x	-.--%	25.36B
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	28.85x	7.09x	18.42x	1.91%	405.29B
Weighted average by Cap.	35.19x	8.35x	20.45x	1.79%